Skip to main content
IMS Events Main banner

  1. Home

  • Wednesday, Sep 17th
    11:00 - 11:10 East Coast USA Time
    (OA-29) In Situ Visualisation of BCMA Bispecific Antibody and the Myeloma Immune Microenvironment
    Location: Room 718
    Abstract Presenter: Jeremy Er, Bmed Sci, MBBS, FRACP, FRCPA – Hawkins laboratory, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia Clinical haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia
    Myeloma Genomics and Microenvironment and immune profiling
  • Wednesday, Sep 17th
    11:10 - 11:20 East Coast USA Time
    (OA-31) A Comprehensive Map of Genomic Drivers of Resistance to Anti-BCMA Immunotherapies in Multiple Myeloma
    Location: Room 718
    Abstract Presenter: Francesco Maura, MD – Memorial Sloan Kettering
    Myeloma Genomics and Microenvironment and immune profiling
  • Wednesday, Sep 17th
    12:32 - 12:38 East Coast USA Time
    (PA-255) Multi-hit Cytogenetics Risk Events Associated with IFN-I Suppression across TME of NDMM Patients and Poor Outcomes
    Location: Room 714A
    Abstract Presenter: William C. Pilcher, Jr., BsC (he/him/his) – Emory University
    Myeloma Genomics and Microenvironment and immune profiling
  • Wednesday, Sep 17th
    16:30 - 16:40 East Coast USA Time
    (OA-27) Composition and Functional State of T and NK Cells in Extramedullary Myeloma Tumor Microenvironment
    Location: Room 718
    Abstract Presenter: Anjana Anilkumar Sithara, MS – University of Ostrava
    Myeloma Genomics and Microenvironment and immune profiling
  • Wednesday, Sep 17th
    16:50 - 17:00 East Coast USA Time
    (OA-28) Midnolin Downregulation Promotes Myelomagenesis via Impacting Ubiquitination Independent Pathway of Protein Degradation
    Location: Room 718
    Abstract Presenter: Anna Besschetnova, PhD (she/her/hers) – Dana-Farber Cancer Institute
    Myeloma Genomics and Microenvironment and immune profiling
  • Wednesday, Sep 17th
    17:00 - 17:10 East Coast USA Time
    (OA-72) Deciphering Myeloid Cell Dynamics within the Osteolytic Lesion Tumor Microenvironment to Overcome Immunosuppression in Multiple Myeloma
    Location: Room 718
    Abstract Presenter: Joshua Rivera, PhD – Dana-Farber Cancer Institute
    Myeloma Genomics and Microenvironment and immune profiling
  • Wednesday, Sep 17th
    17:10 - 17:20 East Coast USA Time
    (OA-73) Longitudinal Multi-Omic Profiling Uncovers Immune Escape and Predictors of Response in Multiple Myeloma
    Location: Room 718
    Abstract Presenter: Denis J. Ohlstrom (he/him/his) – Georgia Institute of Technology
    Myeloma Genomics and Microenvironment and immune profiling
  • Thursday, Sep 18th
    16:40 - 16:50 East Coast USA Time
    (OA-32) Idecabtagene Vicleucel (ide-cel) and Endogenous Immune Profiles Linked to Progression-Free Survival in Relapsed/Refractory Multiple Myeloma (RRMM) Patients
    Location: Room 718
    Abstract Presenter: Bruno Paiva, PhD – Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain
    Myeloma Genomics and Microenvironment and immune profiling
  • Friday, Sep 19th
    13:41 - 13:59 East Coast USA Time
    (OA-30) Single-Cell Immune Landscape Associated with Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone Induction Efficacy in Newly Diagnosed Myeloma
    Location: Hall FG
    Abstract Presenter: Ludovic Martinet, PhD (he/him/his) – Cancer research center of Toulouse, iuct-oncopole, CHU Toulouse
    Myeloma Genomics and Microenvironment and immune profiling
  • Friday, Sep 19th
    14:03 - 14:21 East Coast USA Time
    (OA-33) High-Risk Genomic Consensus Model Validation in a Large Cohort of Newly Diagnosed Multiple Myeloma Patients Using Next Generation Sequencing
    Location: Hall FG
    Abstract Presenter: Anais Schavgoulidze, PharmD PhD (she/her/hers) – IUCT Oncopole Toulouse
    Myeloma Genomics and Microenvironment and immune profiling